Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: A systematic review

Journal of Clinical Psychiatry

Volumn 64, Issue 8, 2003, Pages 890-897

  Briken, Peer ^a   Hill, Andreas ^a   Berner, Wolfgang ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Antiandrogens; GnRH agonists; LHRH agonists; Paraphilia; Pedophilia; Sex offenders

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; ETIDRONIC ACID; FLUTAMIDE; GONADORELIN AGONIST; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE ENANTATE; TRIPTORELIN; VITAMIN D;

ASTHENIA; BONE DEMINERALIZATION; CLINICAL TRIAL; DECREASED BODY HAIR GROWTH; DECREASED FACIAL HAIR GROWTH; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FOLLOW UP; FORENSIC PSYCHIATRY; GYNECOMASTIA; HAIR DISEASE; HOT FLUSH; HUMAN; HYPERHIDROSIS; HYPOGONADISM; INJECTION PAIN; MALE; MEDICAL LITERATURE; MEDLINE; MYALGIA; NAUSEA; OSTEOPOROSIS; PEDOPHILIA; PRIORITY JOURNAL; PSYCHOTHERAPY; PUBLICATION; RELAPSE; REVIEW; SELF REPORT; SEXUAL CRIME; SEXUAL DEVIATION; SIDE EFFECT; URINE INCONTINENCE; WEIGHT GAIN;

EID: 0041828972     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0806     Document Type: Review

References (38)

1. Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry 1996;153:974-984
2. Bradford JMW. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour. Can J Psychiatry 2001;46:26-33
3. Jannini EA, Screponi E, Carosa E, et al. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. Int J Androl 1999;22:385-392
4. Simon NG, Cologer-Clifford A, Lu SF, et al. Testosterone and its metabolites modulate 5HT1A and 5HT1B agonist effects on intermale aggression. Neurosci Biobehav Rev 1998;23:325-336
5. Kreuz LE, Rose RM. Assessment of aggressive behaviour and plasma testosterone in a young criminal population. Psychosom Med 1972;34:321-332
6. Ehrenkranz J, Bliss E, Sheard MH. Plasma testosterone: correlation with aggressive behaviour and social dominance in man. Psychosom Med 1974;36:469-475
7. Virkkunen M, Rawliongs R, Tokola R, et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994;51:20-27
8. Higley JD, Mehlmann PT, Poland RE, et al. CSF testosterone and 5-HIAA correlate with different types of aggressive behavior. Biol Psychiatry 1996;40:1067-1082
9. Archer J. The influence of testosterone on human aggression. Br J Psychol 1991;82:1-28
10. Gijs I, Gooren L. Hormonal and psychopharmacological interventions in the treatment of paraphilias: an update. J Sex Res 1996;33:273-290
11. Coleman E. Compulsive sexual behaviour: new concept and treatments. J Psychol Hum Sex 1991;2:37-52
12. Kafka M. Psychopharmacological treatment for nonparaphilic compulsive sexual behavior. CNS Spectrums 2000;5:49-59
13. Conn MP, Crowley WF. Gonadotropin releasing hormone and its analogues. N Engl J Med 1991;324:93-103
14. Schwanzel-Fukuda M, Bick D, Pfaff DW. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 1989;6:311-326
15. Rösler A, Witztum E. Pharmacotherapy of the paraphilias in the next millenium. Behav Sci Law 2000;18:43-56
16. Gaffney GR, Berlin FS. Is there a hypothalamic-pituitary-gonadal dysfunction in paedophilia? a pilot study. Br J Psychiatry 1984;145:657-660
17. Bain J, Langevin R, Hucker S, et al. Sex hormones in pedophiles, 1: baseline values of six hormones, 2: the gonadotropin releasing hormone test. Ann Sex Res 1988;1:443-454
18. Allolio B, Keffel D, Deuss U, et al. Behandlung sexueller Verhaltensstörungen mit LH-RH-Superagonisten. Dtsch Med Wochenschr 1985;110:1952
19. Rousseau L, Couture M, Dupont A, et al. Effect of combined androgen blockade with a LHRH agonist and flutamide in one case of male exhibitionism. Can J Psychiatry 1990;35:338-341
20. Marcus AO, Fernandez MP, De Kayser L. Use of gonadotropin releasing hormone analogue in treatment of exhibitionism [abstract]. Clin Res 1993;1:107
21. Dickey R. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry 1992;37:567-569
22. Cooper AJ, Cernowsky ZZ. Comparison of cyproterone acetate (CPA) and leuprolide acetate (LHRH agonist) in a chronic pedophile: a clinical case study. Biol Psychiatry 1994;36:269-271
23. Thibaut F, Cordier B, Kuhn JM. Effect of a long-lasting gonadotropin hormone-releasing hormone agonist in six cases of severe male paraphilia. Acta Psychiatr Scand 1993;87:445-450
24. Thibaut F, Cordier B, Kuhn JM. Gonadotropin hormone releasing hormone agonist in cases of severe paraphilia: a lifetime treatment? Psychoneuroendocrinology 1996;21:411-419
25. Gottesmann H, Yokley J, Sloan D, et al. The use of leuprolide acetate in the treatment of four types of paraphilia. Presented at the 16th annual Research and Treatment Conference of the Association for the Treatment of Sexual Abusers; October 1997; Arlington, Va
26. Hansen H, Lykke-Olesen L. Treatment of dangerous sexual offenders in Denmark. J Forensic Psychiatry 1997;8:195-199
27. Rösler A, Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. N Engl J Med 1998;338:416-422
28. Krueger RB, Kaplan MS. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases. Arch Sex Behav 2001;30:409-422
29. Briken P, Nika E, Berner W. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther 2001;27:45-55
30. Briken P. Pharmacotherapy of paraphilias with luteinizing hormone-releasing hormone agonists [letter]. Arch Gen Psychiatry 2002;59:469-470
31. Grasswick LJ, Bradford JB. Osteoporosis associated with the treatment of paraphilias: a clinical review of seven case reports [abstract]. Forensische Psychiatrie und Psychotherapie 2002;9(suppl):40
32. Czerny JP, Briken P, Berner W. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics. Eur Psychiatry 2002;17:104-106
33. Bradford JMW, Pawlak A. Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Arch Sex Behav 1993;22:383-402
34. Basaria S, Lieb J, Tang AM, et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 2002;56:779-786
35. Vasireddy S, Swinson DR. Male osteoporosis associated with longterm i cyproterone treatment. J Rheumatol 2001;28:1702-1703
36. Reilly DR, Delva NJ, Hudson RW. Protocols of the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Can J Psychiatry 2000;45:559-563
37. Hare RD. The Hare Psychopathy Checklist-Revised. Toronto, Ontario, Canada: Multi-Health Systems; 1991
38. Grossman LS, Martis B, Fichtner CG. Are sex offenders treatable? a research overview. Psychiatr Serv 1999;50:349-361